Malabsorption panel
Testing optimized for accuracy, efficiency, and ease
For individuals affected by chronic diarrhea or unexplained weight loss, timely diagnosis is essential to placing them on the proper treatment pathway and preventing further harm. Stool testing for malabsorption syndromes, which encompass an array of intestinal disorders, can provide information on the cause of chronic symptoms, leading to improved diagnosis and enhanced disease management.
Malabsorption panel Test menu
Malabsorption panel
Traditional testing frequently requires sequential tests, each requiring a separate stool sample. This often results in extended wait times for answers. To expedite and streamline the diagnostic testing experience, we’ve developed a comprehensive malabsorption panel that evaluates for four disease markers with just one stool sample.
Key testing
- MALP | Malabsorption Evaluation Panel, Feces
- Particularly useful for pediatric patients.
- Simplifies the ordering process.
- Quickly rules in or out numerous causes of GI conditions.
- Facilitates patient compliance.
Testing panel includes
- A1AF | Alpha-1-Antitrypsin, Random, Feces
- Tests for protein loss through evaluation of alpha-1-antitrypsin, a protein largely resistant to breakdown and a good marker of how much protein is lost in the stool.
- CALPR | Calprotectin, Feces
- Tests for mucosal and intestinal inflammation through evaluation of the inflammatory marker calprotectin.
- ELASF | Pancreatic Elastase, Feces
- Evaluates for the pancreatic elastase enzyme, which indicates the body’s ability to digest certain proteins and carbohydrates.
- UREDF | Reducing Substance, Feces
- Tests for carbohydrate malabsorption, or malabsorption of glucose or fructose.
Highlights
Puanani Hopson, D.O., explains how Mayo Clinic Laboratories’ malabsorption panel can provide timelier diagnosis for children with chronic diarrhea or unexplained weight loss. The novel panel, which bundles four existing tests, requires just one stool sample.